[Polyoxometalates. A new class of inorganic CK2 inhibitors]

Med Sci (Paris). 2008 Dec;24(12):1012-4. doi: 10.1051/medsci/200824121012.
[Article in French]
No abstract available

Publication types

  • News
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Triphosphate / physiology
  • Animals
  • Anions / chemistry
  • Anions / pharmacology
  • Anti-Infective Agents / chemistry
  • Anti-Infective Agents / pharmacology
  • Anti-Infective Agents / therapeutic use
  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / pharmacology
  • Antineoplastic Agents / therapeutic use
  • Binding Sites / drug effects
  • Binding, Competitive
  • Casein Kinase II / antagonists & inhibitors*
  • Casein Kinase II / chemistry
  • Casein Kinase II / physiology
  • Catalytic Domain / drug effects
  • Clinical Trials, Phase II as Topic
  • Combinatorial Chemistry Techniques
  • Humans
  • Metal Nanoparticles / chemistry*
  • Metal Nanoparticles / therapeutic use
  • Mice
  • Models, Molecular
  • Neoplasm Proteins / antagonists & inhibitors
  • Neoplasms / drug therapy
  • Neoplasms / enzymology
  • Oxygen Compounds / chemistry
  • Oxygen Compounds / pharmacology*
  • Oxygen Compounds / therapeutic use
  • Protein Conformation
  • Protein Kinase Inhibitors / chemistry
  • Protein Kinase Inhibitors / pharmacology*
  • Transition Elements / chemistry
  • Transition Elements / pharmacology*
  • Transition Elements / therapeutic use
  • Xenograft Model Antitumor Assays

Substances

  • Anions
  • Anti-Infective Agents
  • Antineoplastic Agents
  • Neoplasm Proteins
  • Oxygen Compounds
  • Protein Kinase Inhibitors
  • Transition Elements
  • Adenosine Triphosphate
  • Casein Kinase II